25.1 C
New York
Friday, June 12, 2026

Tag: patent

U.S. Drone Land Surveying Market Expected to Reach $6.59 Billion By End Of 2033

MarketNewsUpdates News Commentary NEW YORK, Aug. 14, 2025 /PRNewswire/ -- The global drone market is poised to become one of the most important and fastest-growing...

TechTAC Secures Patent for Slimline QuickSet Tubing Anchor Catcher

The U.S. Patent and Trademark Office has awarded TechTAC® a new patent for its Slimline® QuickSet™ Tubing Anchor Catcher (TAC).

Edible Garden Delivers Strong Performance Across Core and Key Segments, Driven by Strategic Portfolio Transformation

 Company exits low-margin product lines, invests in higher-margin, innovative CEA-informed, better-for-you shelf-stable products, and expands global reach

Allot Announces Second Quarter 2025 Financial Results

Exceptionally strong 73% year-over-year growth in SECaaS ARR; raising full year guidance HOD HASHARON, Israel, Aug. 14, 2025 /PRNewswire/ -- Allot Ltd. (NASDAQ: ALLT) (TASE: ALLT),...

22nd Century Group Reports Second Quarter 2025 Financial Results

VLN® Early Adoption Commercial Activity Expands with Two Partner Brand Launches in Progress – Smoker Friendly and Pinnacle

Minesto publishes Half-Year Report 2025

GOTHENBURG, Sweden, Aug. 14, 2025 /PRNewswire/ -- CEO Dr Martin Edlund: "As the leading pioneer in Ocean Renewable Energy, Minesto moves on with more determination and...

Minesto publishes Half-Year Report 2025

GOTHENBURG, Sweden, Aug. 14, 2025 /PRNewswire/ -- CEO Dr Martin Edlund: "As the leading pioneer in Ocean Renewable Energy, Minesto moves on with more determination and...

DRI Healthcare Reports Second Quarter 2025 Results

Subsequent to the end of the quarter, completed the previously announced transaction to internalize its investment management functionPortfolio assets generate Total Income of $44.1...

Biofrontera Inc. Reports Second Quarter 2025 Financial Results and Provides a Business Update

Woburn, MA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (NASDAQ:BFRI) (the "Company"), a biopharmaceutical company specializing in the development and commercialization of photodynamic therapy in dermatology, today reported financial results for the three and six months ended June 30, 2025 and provided a business update.

Applied Therapeutics Reports Second Quarter 2025 Financial Results

- CMT-SORD program advances; meeting scheduled with the FDA in Q3 2025 to discuss govorestat for the treatment of CMT-SORD

InventHelp Inventor Develops Highly Modified Range Design (KOC-463)

PITTSBURGH, Aug. 13, 2025 /PRNewswire/ -- "I wanted to create a range with an advanced control system, safety features, cooking options and programming capabilities,"...

Whole Genome Sequencing Market to Reach New Heights by 2030

"With cutting-edge advances in next-generation sequencing and growing interest in personalized medicine, whole genome sequencing is set to transform disease diagnosis and treatment, driving...

Daewoong Therapeutics Microneedle Patch Achieves Best-in-Class Bioavailability, Proving the Strength of Its Drug-Delivery Platform

More than 80% relative bioavailability compared with injectable obesity therapy, well above the roughly 30% reported for existing microneedle patches and setting a new...

Smartkem Reports Second Quarter 2025 Financial Results

MANCHESTER, England, Aug. 12, 2025 /PRNewswire/ -- Smartkem (Nasdaq: SMTK), which is seeking to change the world of electronics with a new class of...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsPatent